BioLife Solutions, Inc.
General ticker "BLFS" information:
- Sector: Health Care
- Industry: Life Sciences Tools & Services
- Capitalization: $1.2B (TTM average)
BioLife Solutions, Inc. follows the US Stock Market performance with the rate: 43.4%.
Estimated limits based on current volatility of 2.2%: low 25.13$, high 26.24$
Factors to consider:
- Total employees count: 159 (-61.1%) as of 2024
- Top business risk factors: Pandemic risks, Product performance, Labor/talent shortage/retention, Manufacturing risks, Litigation risks
- Price in estimated range
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [16.94$, 32.14$]
- 2025-12-31 to 2026-12-31 estimated range: [14.91$, 29.16$]
Financial Metrics affecting the BLFS estimates:
- Negative: with PPE of -94.1 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Positive: -8.75 < Industry operating profit margin (median), % of -7.19
- Positive: -2.95 < Return on assets ratio (scaled to [-100,100]) of -2.77
- Positive: Shareholder equity ratio, % of 87.34 > 63.39
- Positive: 0.33 < Operating cash flow per share per price, % of 0.69
- Positive: Investing cash flow per share per price, % of 4.80 > -0.66
- Positive: Inventory ratio change, % of -10.06 <= -0.75
Short-term BLFS quotes
Long-term BLFS plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $76.24MM | $75.86MM | $82.25MM |
| Operating Expenses | $82.16MM | $99.30MM | $89.38MM |
| Operating Income | $-5.92MM | $-23.44MM | $-7.13MM |
| Non-Operating Income | $1.07MM | $4.97MM | $-4.30MM |
| Interest Expense | $0.28MM | $1.45MM | $0.72MM |
| R&D Expense | $8.67MM | $12.07MM | $7.91MM |
| Income(Loss) | $-4.85MM | $-18.47MM | $-11.43MM |
| Taxes | $-5.24MM | $-0.02MM | $-0.04MM |
| Other Income(Loss) | $-140.19MM | $-49.55MM | $-8.80MM |
| Profit(Loss)* | $-280.00MM | $-66.43MM | $-28.98MM |
| Stockholders Equity | $364.19MM | $337.66MM | $348.91MM |
| Inventory | $34.90MM | $43.46MM | $29.01MM |
| Assets | $450.23MM | $412.71MM | $399.49MM |
| Operating Cash Flow | $-8.49MM | $-12.50MM | $8.43MM |
| Capital expenditure | $10.38MM | $6.38MM | $3.23MM |
| Investing Cash Flow | $-58.12MM | $17.84MM | $58.30MM |
| Financing Cash Flow | $16.32MM | $10.59MM | $-6.78MM |
| Earnings Per Share** | $-6.59 | $-1.52 | $-0.63 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.